Merck
HomeWebinarsThe Future of Pharma and Biopharmaceutical Audits

The Future of Pharma and Biopharmaceutical Audits



WEBINAR

SARS-CoV-2 showed us that technology supports us during our inspection activity even if on-site visits are not possible. Travel restrictions of various kinds will remain a risk in the future. The use of new technologies has shown that inspections and audits can be carried out despite these restrictions. We will focus on what possibilities the new technologies offer and take a look at the future of inspections and audits.

In this webinar, you will learn:

  • Regulatory overview of remote audits
  • The technologies needed to support the audit process
  • What types of inspections are possible with the use of these technologies
  • How audits may look in the future